Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the PIONEER study
about
China Experts Consensus on the Diagnosis and Treatment of Advanced Stage Primary Lung Cancer (2016 Version)Non-small cell lung cancer genomics around the globe: focus on ethnicityA multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysisComparison of the efficacy and tolerability of gefitinib with pemetrexed maintenance after first-line platinum-based doublet chemotherapy in advanced lung adenocarcinoma: single-center experience.The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancerRacial and Ethnic Differences in the Epidemiology and Genomics of Lung Cancer.Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations.Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China.Clinical profiles and trend analysis of newly diagnosed lung cancer in a tertiary care hospital of East China during 2011-2015.Clinical efficacy evaluation of tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations.EGFR G796D mutation mediates resistance to osimertinib.Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patientsApplicability of graded prognostic assessment of lung cancer using molecular markers to lung adenocarcinoma patients with brain metastases.Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations.Beyond chemotherapy for advanced disease-the role of EGFR and PD-1 inhibitors.Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients.Multicenter study of diagnostic procedures, genetic aberration analysis, and first-line treatment of lung cancer in Jiangsu Province, China.Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-old.On Enrichment Strategies for Biomarker Stratified Clinical Trials.Uncommon EGFR mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinum-based chemotherapy.Detection of EGFR and BRAF mutations by competitive allele-specific TaqMan polymerase chain reaction in lung adenocarcinoma.[Research Progress of Targeted Therapy for EGFR Gene in Non-small Cell Lung Cancer].Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer.Immunotherapy in the Asiatic population: any differences from Caucasian population?Q56893519Epidermal growth factor receptor T790M mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern ChinaQ58714451
P2860
Q28073920-7F229F47-5B7D-4857-92A4-CE666582A81FQ33639292-BD2584A7-4C1D-4576-A107-E3CD19EF5FD9Q33868401-84B94CDE-4330-4CB0-8E06-09FB860390B7Q36163279-74EA1400-16E9-4FAB-AF1B-F134BFAE8208Q37354160-2B2DB07B-423D-4CEF-A458-DD5CF8950CB8Q37581446-3A95AD4E-E6BE-4210-A5E3-C8066CC366CDQ37684483-ED53A2A0-6229-4171-8BD2-B4C44A21D722Q37697306-AF30C9E9-FBCA-4268-AF22-DAFA6DFE9EA5Q37716487-9F79B043-AD5A-4735-B713-3EC491A94DA7Q38608924-D8A74979-0D39-4B5D-BD26-2C72799AC556Q41016042-658BED91-6C2E-44B3-BB31-930CC15D757FQ41472663-F911384D-7DBA-4747-A9ED-5437E3690C50Q42362771-F4C1C1E3-E0CC-4C72-BA26-7871D01A76D8Q42378468-F23D1C27-6220-471A-822F-DF402A714BBBQ46885929-EF2228D0-6E61-43D7-9F39-00BFD0FC2579Q47136456-2D113862-88E7-45EE-AF02-26856E2CC0E7Q47611571-A8AD85AC-6105-4331-B524-FA243D80D0BEQ47654942-BD476D3A-CFC0-4894-9BDF-D0D4264BD998Q47962254-91757BAD-2A7F-4E9A-8BCA-03DDBEBBBFADQ48654563-A489F372-050B-46C3-84D1-78B072E8FF93Q49379624-2ECAED7E-A3D8-4E05-8837-4BE65B2BEB8FQ50192132-7854730A-7352-4F88-B1A8-4AFCF2D38DC4Q53753373-DBC7E709-E91A-43C2-9AB5-DFD2393F8502Q54967623-FA96B71B-ABC6-4DA4-B705-6CDDD9B58F7CQ55312983-9F8D1FAF-1ECA-47D2-B12A-75DCBDA11478Q56893519-924CA7B8-C117-44C7-9CB0-DF66E1E89797Q58603542-BDDCB797-2B9A-4A54-ADB2-344C9AC5FCDEQ58714451-54F6DA03-1E33-4E08-8F00-7545B8602F7A
P2860
Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the PIONEER study
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Molecular Epidemiology of EGFR ...... Analysis of the PIONEER study
@ast
Molecular Epidemiology of EGFR ...... Analysis of the PIONEER study
@en
type
label
Molecular Epidemiology of EGFR ...... Analysis of the PIONEER study
@ast
Molecular Epidemiology of EGFR ...... Analysis of the PIONEER study
@en
prefLabel
Molecular Epidemiology of EGFR ...... Analysis of the PIONEER study
@ast
Molecular Epidemiology of EGFR ...... Analysis of the PIONEER study
@en
P2093
P2860
P1433
P1476
Molecular Epidemiology of EGFR ...... Analysis of the PIONEER study
@en
P2093
Guoqing Liao
Junling Li
Kaican Cai
Liang'an Chen
Ligong Nie
Meizhen Zheng
Mengzhao Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0143515
P407
P577
2015-11-23T00:00:00Z